These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 31773789)

  • 1. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
    J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
    Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cornuside alleviates psoriasis-like skin lesions in mice by relieving inflammatory effects.
    Yan F; Wang L; Zhang J; Liu Z; Yu B; Li W; Guo Z; Shi D; Zhang H; Xiong H
    Int Immunopharmacol; 2024 Jun; 134():112183. PubMed ID: 38705031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
    Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
    Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
    Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased microRNA-126 expression in psoriatic CD4
    Wu R; Li X; Li S; Tang G; Zhang S; Zhu Y; Zhang X; Deng M; Tan S; Luo S; Zhang Q; Zhao M; Zhang P; Su Y
    J Dermatol; 2022 Apr; 49(4):432-440. PubMed ID: 34931339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
    Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
    Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
    Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.